Strategies for Prevention of Infection in Short-Duration Neutropenia

Infection Control and Hospital Epidemiology

Volumn 19, Issue 8, 1998, Pages 590-592

  Fenelon, Lynda ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASEPSIS; DISEASE TRANSMISSION; HOSPITAL; HUMAN; INFECTION; INFECTION CONTROL; METHODOLOGY; NEUTROPENIA; PATIENT CARE;

ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; ASEPSIS; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; HOSPITALS; HUMANS; INFECTION; INFECTION CONTROL; NEUTROPENIA; PATIENT ISOLATION;

EID: 0032129937     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141786     Document Type: Article

References (17)

1. Roilides E, Pizzo PA. Perspectives on the use of cytokines in the management of infectious complications of cancer. Clin Infect Dis 1993;17(suppl 2):S385-S389.
2. Gorin NC, Coiffier B, Hayat M, Fouillard L, Kuentz M, Flesch M, et al. Recombinant human granulocyte-macrophage colony-stimulating factor after high dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind, placebo-controlled trial. Blood 1992;80:1149-1157.
3. Reichman BS, Seidman AD, Crown JPA, Heelan R, Hakes TB, Lebwohl DE, et al. Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol 1993;11:1943-1951.
4. Terpestra W, Lowenberg B. Application of myeloid growth factors in the treatment of acute myeloid leukaemia. Leukaemia 1997;11:315-327.
5. Iwen PC, Reed EC, Armitage JO, Bierman PJ, Kessinger A, Vose JM, et al. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol 1993;14:131-139.
6. Kolbe K, Domkin D, Derigs HG, Bhakdi S, Huber C, Aulitzky WE. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997;19: 143-147.
7. Wald A, Leisenring W, Von Bunk JO, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997;175:1459-1466.
8. Levine AS, Siegal SE, Schreiber AD, Hauser J, Preisler HD, Goldstein IM, et al. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukaemia. N Engl J Med 1973;288:477-483.
9. Buckner CD, Clift RA, Sanders JE, Meyers JD, Counts GW, Farewell VT, et al. Protective environment for marrow transplant recipients. Ann Intern Med 1978; 89:893-901.
10. Schimpff SC, Greene WH, Young V, Fortner CL, Jepson A, Cusack N, et al. Infection prevention in acute non-lymphocytic leukaemia. Laminar air flow room reverse isolation with oral non-absorbable antibiotic prophylaxis. Ann Intern Med 1975;82:351-358.
11. Bodey GP, Johnston D. Microbiological evaluation of protected environments during patient occupancy. Appl Microbiol 1971;22:828-836.
12. Barnes RA, Rogers TR. Control of an outbreak of nosocomial aspergillosis by laminar airflow isolation. J Hosp Infect 1989;14:89-94.
13. Nauseef WM, Maki DG. A study of the value of simple protective isolation in patients with granulocytopenia. N Engl J Med 1981;304:448-453.
14. Kruger W, Stockschlader M, Zander AR. Transmission of rotavirus diarrhea in a bone marrow transplantation unit by a hospital worker. Bone Marrow Transplantation 1991;8:507-508. Letter.
15. Harrington RD, Hooton TM, Hackman RC, Storch GA, Osborne B, Benson A, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant centre. J Infect Dis 1992;165:987-993.
16. Remington JS, Schimpff SC. Please don't eat the salads. N Engl J Med 1981;304:433-434.
17. Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B, Ringden O. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomised controlled study. Support Care Cancer 1997;5:485-488.